Relay Therapeutics added net 7 people over 90 days, channeling new talent into operations (now the largest function at 20 people). The company brought in a VP of Clinical Operations and three director-level roles in regulatory affairs, physician science/oncology R&D, and medical science liaison for APAC—signaling a push toward late-stage clinical execution and global commercialization readiness. Inbound talent came from Agios, AstraZeneca, Bicycle Therapeutics, Cytokinetics, and Daiichi Sankyo (one each), while the only departures were two entry-level contracts attorneys to Watts Water Technologies.
Hires, exits and promotions across Relay Therapeutics and its rivals — every Monday. Drop your email, no account needed.
One short email a week. Unsubscribe anytime.
New hires per month, last 12 months. 13 total hires.
Hires, exits and promotions over the last 90 days — by role and function.
Sign up to Inkling to access all data.
Unlock with Inkling →Net change by function, last 90 days.
No elevated cluster of senior exit signals right now. Inkling flags one when it appears — track this market.
Which companies Relay Therapeutics hires from — and loses people to — over the last 90 days.
Inkling watches the people at every company you compete with and briefs you weekly
— the hire before the launch, the exit before it shows on their profile.
More live desks
Aggregate signals refresh weekly. Moves are drawn from public profiles and reported by role — we never name individuals on this page.